These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12525828)

  • 1. Immunotherapy. Oral route to Holy Grail?
    Palù G; Parolin C
    Gene Ther; 2003 Jan; 10(1):1-2. PubMed ID: 12525828
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS/HIV. A STEP into darkness or light?
    Moore JP; Klasse PJ; Dolan MJ; Ahuja SK
    Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy progress and prospects: novel gene therapy approaches for AIDS.
    Wolkowicz R; Nolan GP
    Gene Ther; 2005 Mar; 12(6):467-76. PubMed ID: 15703764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
    Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
    Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate AIDS vaccines.
    Graham BS; Wright PF
    N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
    Rivière C; Danos O; Douar AM
    Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine that delivers rather than induces antibodies.
    Letvin NL
    Gene Ther; 2009 Nov; 16(11):1283-4. PubMed ID: 19759565
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration.
    Takamura S; Niikura M; Li TC; Takeda N; Kusagawa S; Takebe Y; Miyamura T; Yasutomi Y
    Gene Ther; 2004 Apr; 11(7):628-35. PubMed ID: 14973544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. India targets local HIV strain in test of AIDS vaccine.
    Jayaraman KS
    Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
    Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
    Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus].
    Liu YZ; Zhou L; Wang Q; Ye SQ; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):251-4. PubMed ID: 15640860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular basis for HIV infection: implication for the therapy].
    Nakaya T; Fujinaga K; Nishino Y; Kishi M; Ikuta K
    Tanpakushitsu Kakusan Koso; 1994 Jun; 39(8):1411-24. PubMed ID: 8016374
    [No Abstract]   [Full Text] [Related]  

  • 19. [The virus can not yet be eradicated. "HIV-infected patients cannot be completely cured"].
    Hellbom K
    Krankenpfl J; 1998; 36(7-8):274. PubMed ID: 9775853
    [No Abstract]   [Full Text] [Related]  

  • 20. Milking gene therapy.
    Alton EW; Griesenbach U; Geddes DM
    Nat Med; 1998 Oct; 4(10):1121-2. PubMed ID: 9771739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.